HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yasukawa, T. Articles by Fujisawa, T. Search for Related Content PubMed PubMed Citation Articles by Yasukawa, T. Articles by Fujisawa, T.

Usefulness of PET with ¹¹C-Methionine for the Detection of Hilar and Mediastinal Lymph Node Metastasis in Lung Cancer

Institute of Pulmonary Cancer Research, Chiba University School of Medicine, Chiba
Research Center of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan

Correspondence: For correspondence or reprints contact: Tomohisa Yasukawa, MD, Institute of Pulmonary Cancer Research, Chiba University School of Medicine, Department of Surgery, 1-8-1 Inohana, Chuo-ku, Chiba 260-6670, Japan.

ABSTRACT

We retrospectively evaluated the usefulness of PET with ¹¹C-methionine (methionine PET) for the diagnosis of lymph node metastases in patients with lung cancer. Methods: Methionine PET and CT were performed before surgical intervention in 41 patients with primary lung cancer. We evaluated individual lymph nodes by methionine PET along with corresponding CT images. The ¹¹C-methionine accumulation of lymph nodes was assessed semiquantitatively by analysis of the tumor-to-muscle ratio (TMR) and was compared with CT and histological diagnoses. Results: A total of 126 lymph nodes, 36 of which were histotogically diagnosed as metastatic, were assessed by CT and methionine PET. The TMR in metastatic lymph nodes (n = 36) was 5.15 ± 1.69, whereas that of nonmetastatic lymph nodes (n = 90) was 2.91 ± 0.76; this difference was significant (P < 0.0001). The most adequate TMR cutoff value for diagnosis of metastasis based on the results of receiver operating characteristic curve analysis was 4.1. The positive and negative predictive values, sensitivity, specificity, and accuracy of methionine PET were 79.5%, 94.3%, 86.1%, 91.1%, and 89.7%, respectively, and were superior to those of CT (57.6%, P = 0.04; 81.7%, P = 0.008; 52.8%, P = 0.002; 84.4%, NS; and 75.4%, P = 0.002, respectively). All positive nodes that were shown to be true-positive by CT, and 12 of 17 false-negatives on CT were correctly diagnosed by PET. Ten of 14 lymph nodes that were false-positive on CT were also correctly diagnosed by PET. Conclusion: Methionine PET appears to be superior to CT for the diagnosis of lymph node metastasis in lung cancer patients. The high negative predictive value of methionine PET suggests that cases in which lymph nodes are enlarged on CT with negative PET analysis may be diagnosed as negative for metastasis.

Key Words: PET • ¹¹C-methionine • lung cancer • lymph node metastasis

This article has been cited by other articles:

				K. Kaira, N. Oriuchi, Y. Otani, K. Shimizu, S. Tanaka, H. Imai, N. Yanagitani, N. Sunaga, T. Hisada, T. Ishizuka, et al. Fluorine-18-{alpha}-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study Clin. Cancer Res., November 1, 2007; 13(21): 6369 - 6378. [Abstract] [Full Text] [PDF]

				G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF]

				A. Ebihara, H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Uno, I. Kuwahira, and K. Eguchi Characteristics of Advantages of Positron Emission Tomography over Computed Tomography for N-staging in Lung Cancer Patients Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 694 - 698. [Abstract] [Full Text] [PDF]

				H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1087 - 1092. [Abstract] [Full Text] [PDF]

				E. Chesnay, E. Babin, J. M. Constans, D. Agostini, A. Bequignon, A. Regeasse, F. Sobrio, and S. Moreau Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C-Methionine PET, Correlation with Morphologic Response, and Clinical Outcome J. Nucl. Med., April 1, 2003; 44(4): 526 - 532. [Abstract] [Full Text] [PDF]

				P. L. Jager, H. J.M. Groen, A. van der Leest, J. W.G. van Putten, R. M. Pieterman, E. G.E. de Vries, and D. A. Piers L-3-[123I]Iodo-{{alpha}}-Methyl-Tyrosine SPECT in Non-Small Cell Lung Cancer: Preliminary Observations J. Nucl. Med., April 1, 2001; 42(4): 579 - 585. [Abstract] [Full Text]

				P. L. Jager, W. Vaalburg, J. Pruim, E. G.E. de Vries, K.-J. Langen, and D. A. Piers Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology J. Nucl. Med., March 1, 2001; 42(3): 432 - 445. [Abstract] [Full Text]